Frontiers in Oncology | Hematologic Malignancies

Review

Published on 04 Oct 2023

Location, location, location: mapping the lymphoma tumor microenvironment using spatial transcriptomics

in Hematologic Malignancies

Keir Pickard
Emily Stephenson
Alex Mitchell
Laura Jardine
Chris M. Bacon

Frontiers in Oncology

doi 10.3389/fonc.2023.1258245

5,682 views
2 citations

Editorial

Published on 04 Oct 2023

Editorial: Biological aspects of bone marrow failure

in Hematologic Malignancies

Panagiotis Diamantopoulos
Serine Avagyan
Elena Solomou

Frontiers in Oncology

doi 10.3389/fonc.2023.1295823

1,159 views

Mini Review

Published on 04 Oct 2023

Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling—a Singaporean experience

in Hematologic Malignancies

Hui-Lin Chin
Joyce Ching Mei Lam
Dheepa Christopher
Poon Limei Michelle
Benedict Yan Junrong

Frontiers in Oncology

doi 10.3389/fonc.2023.1182639

2,376 views
2 citations

Original Research

Published on 03 Oct 2023

Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma

in Hematologic Malignancies

Christos Panayi
Ayse U. Akarca
Alan D. Ramsay
Ananth G. Shankar
Brunangelo Falini
Miguel A. Piris
David Linch
Teresa Marafioti

Frontiers in Oncology

doi 10.3389/fonc.2023.1267604

2,537 views
3 citations

Original Research

Published on 03 Oct 2023

Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era

in Hematologic Malignancies

Reena Nair
Gull Mohammad Bhat
Narendra Agrawal
Manju Sengar
Pankaj Malhotra
Soniya Nityanand
Chitra Lele
Pramod Reddy
Suresh Kankanwadi
Narendra Maharaj

Frontiers in Oncology

doi 10.3389/fonc.2023.1248723

2,668 views
2 citations

Mini Review

Published on 02 Oct 2023

The interplay of FLT3 and CXCR4 in acute myeloid leukemia: an ongoing debate

in Hematologic Malignancies

Laura Klement
Julia Drube

Frontiers in Oncology

doi 10.3389/fonc.2023.1258679

2,495 views
2 citations

Case Report

Published on 02 Oct 2023

Case Report: A recurrent case of ALK-ALCL after autologous transplantation was successfully treated with BV + a modified CHEP chemotherapy containing mitoxantrone hydrochloride liposome with the addition of chidamide maintenance therapy

in Hematologic Malignancies

Zhen Shang
Qi Zhang
Wanying Liu
Jiaying Wu
Yicheng Zhang
Yi Xiao

Frontiers in Oncology

doi 10.3389/fonc.2023.1242552

2,254 views

Review

Published on 02 Oct 2023

Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling

in Hematologic Malignancies

Rahul Banerjee
Kara I. Cicero
Sarah S. Lee
Andrew J. Cowan

Frontiers in Oncology

doi 10.3389/fonc.2023.1240966

5,122 views
13 citations

Case Report

Published on 29 Sep 2023

Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report

in Hematologic Malignancies

Petruta Gurban
Cristina Mambet
Anca Botezatu
Laura G. Necula
Ana I. Neagu
Lilia Matei
Ioana M. Pitica
Saviana Nedeianu
Mihaela Chivu-Economescu
Coralia Bleotu

Frontiers in Oncology

doi 10.3389/fonc.2023.1266996

2,592 views
2 citations

Mini Review

Published on 29 Sep 2023

Biological insights into the role of TET2 in T cell lymphomas

in Hematologic Malignancies

Shannon A. Carty

Frontiers in Oncology

doi 10.3389/fonc.2023.1199108

3,309 views

Original Research

Published on 27 Sep 2023

High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation

in Hematologic Malignancies

Damian Mikulski
Mateusz Nowicki
Izabela Dróźdż
Małgorzata Misiewicz
Kacper Piotr Kościelny
Karol Okoński
Kinga Krawiec
Ewelina Perdas
Agnieszka Wierzbowska
Wojciech Fendler

Frontiers in Oncology

doi 10.3389/fonc.2023.1250355

2,657 views
7 citations

Review

Published on 26 Sep 2023

Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?

in Hematologic Malignancies

Yan-Ying Li
Liu-Yun Zhang
Yun-Hui Xiang
Dan Li
Juan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1127407

4,990 views
9 citations

Original Research

Published on 25 Sep 2023

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential

in Hematologic Malignancies

Estevão Carlos Silva Barcelos
Chiara Rompietti
Francesco Maria Adamo
Erica Dorillo
Filomena De Falco
Beatrice Del Papa
Stefano Baldoni
Manuel Nogarotto
Angela Esposito
Silvia Capoccia

Frontiers in Oncology

doi 10.3389/fonc.2023.1218989

3,385 views
8 citations

Review

Published on 22 Sep 2023

Updates in pathobiological aspects of anaplastic large cell lymphoma

in Hematologic Malignancies

Rui Wu
Megan S. Lim

Frontiers in Oncology

doi 10.3389/fonc.2023.1241532

4,830 views
4 citations

Original Research

Published on 20 Sep 2023

The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients

in Hematologic Malignancies

Weiqin Yao
Haifei Yang
Hongying You
Jingjing Shang
Yingying Zhai
Zhi Yan
Shuang Yan
Xiaolan Shi
Ying Yao
Jing Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1266868

1,985 views
3 citations

Original Research

Published on 19 Sep 2023

Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma

in Hematologic Malignancies

Yan Zhuang
Chenyu Li
Hua Jiang
Lu Li
Yuanteng Zhang
Wei Yu
WeiJun Fu

Frontiers in Oncology

doi 10.3389/fonc.2023.1264422

4,033 views